MRZM
Marizyme, Inc.

17
Mkt Cap
$132.00
Volume
20,000.00
52W High
$0.1195
52W Low
$0.00
PE Ratio
0.00
MRZM Fundamentals
50D MA
$0.00
Beta
-10.53
Avg. Volume
869.57
P/B
0.00
Loading...
Loading...
Marizyme, Inc. is a medical technology company, which engages in the acquisition, development, and commercialization of therapies that minimize mortality and costs in the acute care space. It offers DuraGraft, a one-time intraoperative vascular graft treatment that improves clinical outcomes by reducing the incidence and complications of graft failure, and Krillase, a patented protease-based therapeutic. The company was founded on March 20, 2007 and is headquartered in Jupiter, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Marizyme Inc?
What is the 52-week high for Marizyme Inc?
What is the 52-week low for Marizyme Inc?
What is the PE ratio of Marizyme Inc?
What is the Price-to-Book ratio of Marizyme Inc?
What is the 50-day moving average of Marizyme Inc?

Latest MRZM News

View
No MRZM news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.